Merck Tbk

MERK · JK · Healthcare / Drug Manufacturers - Specialty & Generic

3,460.00IDR+10.00 (+0.29%)

Price History

Full chart

Market Stats

Previous Close3,450.00

Open3,450.00

Day Range3,430.00 – 3,500.00

52-Week Range2,554.08 – 4,179.40

Volume18.40K

Market Cap1.66T

P/E (TTM)4.78

Forward P/E0.00

EPS774.40

Dividend Yield7.75%

Beta0.17

50-Day Avg3,882.00

200-Day Avg3,609.80

About

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Evie Yulin
Employees358
HeadquartersJl. TB Simatupang No. 8, Jakarta Timur, Indonesia, 13760, Indonesia
Websitehttps://www.merckgroup.com/id-id

Leadership

Ms. Evie YulinPresident Director & Biopharma Director · b. 1967
Mr. Bambang NurcahyoFinance Director & Director · b. 1970
Eduan TjongSupply Chain & Operation Manager
Miranda AndamsariCompliance Officer
Taufiq WibowoHead of Legal
Ms. Melisa SandriantiCorporate Secretary & Corporate Communications Manager · b. 1978
Aquira Kurniawati MoeladiHuman Resource Head
Mr. Arryo Aritrixso Teguh Putranto WachjuwidajatPlant Director & Independent Director · b. 1972
Ms. Pachita RamadhaniHead of Internal Audit Unit & Sr Finance Manager · b. 1980
Bundi JanniusHead of Site Pharma Tech

Financials

Income Statement

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	183.81B	224.07B	220.92B	296.32B	373.34B	386.35B	487.60B	547.24B	637.13B	751.40B	795.69B	918.53B	929.88B	1.19T	863.21B	983.45B	1.03T	1.16T	611.96B	744.63B	655.85B	1.06T	1.12T	961.43B	1.04T	1.20T
Growth (%)	-	+21.91%	-1.41%	+34.13%	+25.99%	+3.48%	+26.21%	+12.23%	+16.43%	+17.93%	+5.89%	+15.44%	+1.24%	+28.40%	-27.70%	+13.93%	+5.22%	+11.77%	-47.09%	+21.68%	-11.92%	+62.29%	+5.66%	-14.51%	+7.83%	+15.81%
Cost of Revenue	75.39B	88.25B	88.55B	114.60B	157.08B	171.65B	202.77B	228.99B	275.66B	313.77B	353.72B	436.39B	505.43B	648.47B	404.75B	487.19B	492.61B	568.65B	400.27B	421.32B	361.64B	665.71B	697.01B	560.96B	634.08B	638.23B
Gross Profit	-	-	-	-	-	214.69B	284.83B	318.24B	361.48B	437.63B	441.97B	482.14B	424.44B	545.48B	458.46B	496.26B	542.19B	587.99B	211.69B	323.31B	294.21B	398.68B	427.59B	400.47B	402.67B	562.44B
Gross Margin	-	-	-	-	-	55.57%	58.41%	58.15%	56.73%	58.24%	55.55%	52.49%	45.65%	45.69%	53.11%	50.46%	52.40%	50.84%	34.59%	43.42%	44.86%	37.46%	38.02%	41.65%	38.84%	46.84%
Operating Expense	-	-	-	-	-	132.70B	165.29B	194.39B	221.32B	236.18B	287.43B	203.51B	283.19B	315.45B	258.02B	309.74B	328.90B	379.50B	164.56B	197.72B	185.67B	207.16B	188.52B	200.74B	209.70B	242.01B
Operating Income	55.26B	70.27B	51.15B	68.22B	82.92B	82.00B	119.53B	123.85B	140.15B	201.45B	154.55B	278.63B	141.25B	230.03B	200.44B	186.51B	213.30B	208.49B	47.13B	125.59B	108.53B	191.53B	239.07B	199.73B	192.96B	320.43B
Operating Margin	30.07%	31.36%	23.16%	23.02%	22.21%	21.22%	24.51%	22.63%	22.00%	26.81%	19.42%	30.33%	15.19%	19.27%	23.22%	18.97%	20.61%	18.03%	7.70%	16.87%	16.55%	17.99%	21.26%	20.77%	18.61%	26.69%
EBITDA	-	-	-	-	-	84.53B	124.02B	128.78B	143.29B	217.46B	154.93B	283.65B	152.33B	200.72B	209.31B	197.63B	228.89B	43.97B	55.28B	132.76B	141.27B	231.36B	272.52B	239.49B	232.41B	353.19B
EBITDA Margin	-	-	-	-	-	21.88%	25.44%	23.53%	22.49%	28.94%	19.47%	30.88%	16.38%	16.81%	24.25%	20.10%	22.12%	3.80%	9.03%	17.83%	21.54%	21.74%	24.23%	24.91%	22.42%	29.42%
Net Income	49.37B	56.40B	37.43B	50.58B	57.24B	57.70B	86.54B	89.48B	98.62B	146.70B	118.79B	231.16B	107.81B	175.44B	181.47B	142.55B	153.84B	144.68B	1.16T	78.26B	71.90B	131.66B	179.84B	178.24B	153.46B	243.90B
Net Income Margin	26.86%	25.17%	16.94%	17.07%	15.33%	14.93%	17.75%	16.35%	15.48%	19.52%	14.93%	25.17%	11.59%	14.69%	21.02%	14.49%	14.87%	12.51%	190.10%	10.51%	10.96%	12.37%	15.99%	18.54%	14.80%	20.31%
R&D	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.44B	2.89B	1.80B	3.90B	1.13B	113.50M	188.76M	166.75M	288.16M	541.77M	347.58M	-
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.28%	0.29%	0.17%	0.34%	0.18%	0.02%	0.03%	0.02%	0.03%	0.06%	0.03%	-
Interest Expense	0	0	0	0	0	608.30M	373.31M	489.33M	289.63M	899.79M	792.98M	422.81M	382.78M	282.09M	303.09M	17.17M	323.34M	742.17M	722.44M	2.24B	3.97B	2.64B	3.40B	4.04B	4.54B	1.75B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.16%	0.08%	0.09%	0.05%	0.12%	0.10%	0.05%	0.04%	0.02%	0.04%	0.00%	0.03%	0.06%	0.12%	0.30%	0.61%	0.25%	0.30%	0.42%	0.44%	0.15%

Balance Sheet

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	129.68B	162.72B	172.34B	200.33B	200.47B	218.03B	282.70B	331.06B	375.06B	433.97B	434.77B	584.39B	569.43B	696.95B	716.60B	641.65B	743.93B	847.01B	1.26T	901.06B	929.90B	1.03T	1.04T	957.81B	956.94B	1.27T
Total Liabilities	32.83B	35.23B	23.09B	40.82B	46.43B	37.66B	47.12B	50.83B	47.74B	79.79B	71.75B	90.21B	152.69B	184.73B	162.91B	168.10B	161.26B	231.57B	744.83B	307.05B	317.22B	342.22B	280.41B	161.94B	149.66B	296.49B
Total Equity	96.86B	127.49B	149.24B	159.50B	154.02B	180.36B	235.54B	280.22B	327.32B	354.18B	363.02B	494.18B	416.74B	512.22B	553.69B	473.54B	582.67B	615.44B	518.28B	594.01B	612.68B	684.04B	757.24B	795.88B	807.27B	975.71B
Cash	25.75B	11.84B	6.24B	13.40B	9.77B	24.14B	79.19B	95.25B	134.14B	79.34B	107.90B	253.73B	143.55B	184.23B	257.41B	140.83B	114.44B	59.47B	403.19B	161.47B	134.73B	196.34B	170.43B	201.44B	87.68B	363.85B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.28B	2.87B	1.24B	22.02B	20.28B	16.18B	18.13B	20.21B	14.23B
Net Debt	-	-	-	-	-	-24.14B	-79.19B	-95.25B	-134.14B	-79.34B	-107.90B	-253.73B	-143.55B	-184.23B	-257.41B	-140.83B	-114.44B	-56.18B	-400.32B	-160.22B	-112.70B	-176.06B	-154.25B	-183.30B	-67.47B	-349.62B

Cash Flow

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: IDR	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	39.57B	39.44B	28.29B	64.48B	55.40B	38.99B	91.42B	69.05B	103.73B	81.26B	159.58B	156.23B	88.40B	133.10B	232.83B	160.70B	43.80B	129.92B	168.96B	-210.84B	71.98B	169.81B	110.32B	203.87B	55.71B	376.52B
Investing Cash Flow	-	-	-	-	-	-4.68B	-5.01B	-7.92B	-12.87B	-16.68B	-21.29B	89.41B	-12.88B	-13.07B	-19.89B	-57.52B	-25.48B	-62.40B	1.44T	-29.86B	-31.42B	-43.07B	-20.00B	-19.90B	-16.67B	-15.85B
Financing Cash Flow	-	-	-	-	-	-31.36B	-31.36B	-45.07B	-51.98B	-119.39B	-109.73B	-99.81B	-185.70B	-79.36B	-139.75B	-219.76B	-44.71B	-122.49B	-1.26T	-1.02B	-67.30B	-65.12B	-116.24B	-152.96B	-152.79B	-84.50B
Capital Expenditure	4.48B	7.14B	15.23B	20.06B	9.51B	5.23B	5.82B	8.65B	13.32B	19.07B	22.76B	4.40B	14.57B	15.62B	23.41B	59.15B	25.49B	65.54B	23.86B	29.90B	31.42B	43.09B	20.18B	19.90B	16.83B	15.62B
Free Cash Flow	-	-	-	-	-	33.76B	85.60B	60.40B	90.41B	62.19B	136.82B	151.83B	73.84B	117.48B	209.41B	101.55B	18.31B	64.38B	145.10B	-240.74B	40.56B	126.72B	168.30B	183.97B	38.88B	360.90B
Dividends Paid	25.76B	25.76B	8.92B	47.04B	62.72B	31.36B	31.36B	44.80B	51.52B	119.39B	109.73B	99.81B	185.70B	79.36B	139.75B	219.76B	44.71B	122.49B	1.26T	1.02B	57.64B	55.25B	107.27B	143.89B	142.91B	76.16B
FCF to OCF	-	-	-	-	-	86.58%	93.63%	87.47%	87.16%	76.53%	85.74%	97.18%	83.52%	88.27%	89.94%	63.19%	41.81%	49.55%	85.88%	114.18%	56.34%	74.62%	152.55%	90.24%	69.79%	95.85%
Dividend Paid to FCF	-	-	-	-	-	92.89%	36.64%	74.17%	56.99%	191.97%	80.20%	65.74%	251.50%	67.55%	66.74%	216.41%	244.17%	190.25%	869.28%	-0.42%	142.11%	43.60%	63.74%	78.21%	367.56%	21.10%

Earnings

Report Date	Dec 31, 2005	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Sep 30, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	49.69	3.08	182.69	82.87	79.92	46.15	137.98	89.14	90.07	112.15	88.61	70.46	939.41	134.62	81.91	63.48	63.38	146.83	77.82	112.32	-14.03	116.54	85.04	107.29	25.79	-12.13	24.44	136.58	78.10	-6.41	51.23	37.58	119.01	63.01	80.91	30.96	139.76	135.69	58.81	67.17	103.37	100.57
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.66T

Enterprise Value1.41T

Trailing P/E4.78

Forward P/E0.00

Price / Sales1.23

Price / Book1.78

EPS774.40

Book Value2,152.43

Revenue (TTM)1.35T

Gross Profit (TTM)674.82B

EBITDA457.11B

Profit Margin24.67%

Operating Margin17.78%

Return on Equity37.14%

Return on Assets24.11%

Shares Outstanding448.00M

Shares Float59.80M

Beta0.17

Dividend Yield7.75%

Dividend Rate275.00

Payout Ratio37.01%

Dividends

20261×

275.00Jun 8, 2026

20251×

170.00Jun 25, 2025

20241×

320.00Jun 7, 2024

20231×

320.00May 22, 2023

20221×

240.00Jun 7, 2022

20211×

122.00Jun 25, 2021

20201×

130.00Aug 10, 2020

20183×

2565.00Dec 21, 201853431.40Dec 17, 2018260.00Jul 3, 2018

20171×

275.00Apr 25, 2017

20161×

100.00Apr 6, 2016

20152×

165.00Nov 18, 2015325.00Apr 13, 2015

20141×

312.50Apr 15, 2014

20131×

178.50Apr 15, 2013

20121×

413.50May 11, 2012

20111×

223.20May 9, 2011

20102×

178.50Sep 17, 201066.95Apr 28, 2010

20091×

267.50Apr 27, 2009

20081×

115.00May 9, 2008

20071×

100.00May 21, 2007

20061×

70.00May 17, 2006

Stock Splits

Dec 21, 201520:1